INTERACTION OF AZA ANALOGS OF CHLORPROMAZINE WITH THE DOPAMINE-D2 RECEPTOR

被引:5
|
作者
FAROOQUI, T [1 ]
MARKOVICH, K [1 ]
WALLACE, L [1 ]
MILLER, D [1 ]
URETSKY, N [1 ]
机构
[1] OHIO STATE UNIV,COLL PHARM,DIV PHARMACOL & MED,COLUMBUS,OH 43210
来源
GENERAL PHARMACOLOGY | 1993年 / 24卷 / 01期
关键词
D O I
10.1016/0306-3623(93)90026-T
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Permanently charged AZA analogs of chlorpromazine inhibited the binding of [H-3]spiperone and antagonized the apomorphine-induced inhibition of the potassium evoked release of [H-3]acetylcholine. 2. The AZA analogs were more potent in binding affinity and antagonist activity than the trimethylammonium analog of chlorpromazine but less potent than chlorpromazine. 3. These results suggest that it is possible to enhance the binding of the permanently charged trimethylammonium analog of chlorpromazine by the addition of a functional group near the quaternary nitrogen which is capable of forming a hydrogen bond with the D2 dopamine receptor. 4. However, it appears that for optimal binding, as achieved with chlorpromazine, the hydrogen-bonding proton should be on the charged nitrogen.
引用
收藏
页码:147 / 151
页数:5
相关论文
共 50 条
  • [31] DOPAMINE-D2 RECEPTOR IMAGING WITH SPECT - STUDIES IN DIFFERENT NEUROPSYCHIATRIC DISORDERS
    BRUCKE, T
    PODREKA, I
    ANGELBERGER, P
    WENGER, S
    TOPITZ, A
    KUFFERLE, B
    MULLER, C
    DEECKE, L
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1991, 11 (02): : 220 - 228
  • [32] ALLELIC ASSOCIATION OF HUMAN DOPAMINE-D2 RECEPTOR GENE IN ALCOHOLISM - REPLY
    BLUM, K
    NOBLE, EP
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (14): : 1808 - 1809
  • [33] THE DOPAMINE-D2 RECEPTOR - 2 MOLECULAR-FORMS GENERATED BY ALTERNATIVE SPLICING
    DALTOSO, R
    SOMMER, B
    EWERT, M
    HERB, A
    PRITCHETT, DB
    BACH, A
    SHIVERS, BD
    SEEBURG, PH
    EMBO JOURNAL, 1989, 8 (13): : 4025 - 4034
  • [34] Loss of dopamine-D2 receptor binding sites in parkinsonian plus syndromes
    Hierholzer, J
    Cordes, M
    Venz, S
    Schelosky, L
    Harisch, C
    Richter, W
    Keske, U
    Hosten, N
    Mäurer, J
    Poewe, W
    Felix, R
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (06) : 954 - 960
  • [35] AN ANTIPEPTIDE ANTIBODY THAT RECOGNIZES THE DOPAMINE-D2 RECEPTOR FROM BOVINE STRIATUM
    PLUG, MJ
    DIJK, J
    MAASSEN, JA
    MOLLER, W
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 206 (01): : 123 - 130
  • [36] DOPAMINE UPTAKE BY PLATELETS IS SELECTIVE, TEMPERATURE-DEPENDENT AND NOT INFLUENCED BY THE DOPAMINE-D1 OR DOPAMINE-D2 RECEPTOR
    DEAN, B
    COPOLOV, DL
    LIFE SCIENCES, 1989, 45 (05) : 401 - 411
  • [37] REMOXIPRIDE, A SELECTIVE DOPAMINE-D2 RECEPTOR ANTAGONIST, IN TARDIVE-DYSKINESIA
    ANDERSSON, U
    HAGGSTROM, JE
    NILSSON, MI
    WIDERLOV, E
    PSYCHOPHARMACOLOGY, 1988, 94 (02) : 167 - 171
  • [38] DETECTION AND CHARACTERIZATION OF ADDITIONAL DNA POLYMORPHISMS IN THE DOPAMINE-D2 RECEPTOR GENE
    HAUGE, XY
    GRANDY, DK
    EUBANKS, JH
    EVANS, GA
    CIVELLI, O
    LITT, M
    GENOMICS, 1991, 10 (03) : 527 - 530
  • [39] EXCLUSION OF CLOSE LINKAGE OF BIPOLAR DISORDER TO DOPAMINE-D1 AND DOPAMINE-D2 RECEPTOR GENE MARKERS
    MITCHELL, P
    SELBIE, L
    WATERS, B
    DONALD, J
    VIVERO, C
    TULLY, M
    SHINE, J
    JOURNAL OF AFFECTIVE DISORDERS, 1992, 25 (01) : 1 - 11
  • [40] INTERACTION BETWEEN DOPAMINE-D1 AND DOPAMINE-D2 RECEPTORS IN THE DEVELOPMENT OF DYSTONIA AND HYPERSENSIBILITY IN CEBUS MONKEYS
    HANSEN, L
    GERLACH, J
    PSYCHOPHARMACOLOGY, 1991, 103 (04) : B8 - B8